Drugs / Montanide (Registered Trademark) ISA-51 VG Adjuvant
Montanide (Registered Trademark) ISA-51 VG Adjuvant
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05642195 Background | Jul 2026 → Dec 2033 | non-small cell lung carcinoma | National Cancer Institute (NCI) | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Montanide (Registered Trademark) ISA-51 VG Adjuvant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05642195 ↗ |
| Route | Subcutaneous | “H1299 cell lysate with Montanide (Registered Trademark) ISA-51 VG adjuvant vaccine via subcutaneous injections once every cycle” NCT05642195 ↗ |